Answers are grounded in this paper and cite their sources.
The longer OS at 3 years and higher CR rate with VCAP-AMP-VECP compared with biweekly CHOP suggest that VCAP-AMP-VECP might be a more effective regimen at the expense of higher toxicities, providing the basis for future investigations in the treatment of ATLL.
No takes yet. Share an insight, caveat, or question.
Tsukasaki et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: